Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/22/21
End: 01/22/23
Due: 01/22/24
Phase: N/A
Priority: Normal
Start: 08/20/21
End: 08/19/22
Due: 08/19/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Sitravatinib in Metastatic Breast Cancer | NCT04123704 | Xiang Zhang | user2@example.com | None | 2021-09-22 | 2023-01-22 | 2024-01-22 | - | - | 2025-07-14 |
| Quantitative Assessment of Diffusion Spectrum Imaging in Breast Cancer | NCT05159323 | Xiang Zhang | user2@example.com | None | 2021-08-20 | 2022-08-19 | 2023-08-19 | - | - | 2025-07-14 |